These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 29515071

  • 41. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
    Andries G, Karass M, Yandrapalli S, Linder K, Liu D, Nelson J, Pawar R, Chugh S.
    Exp Hematol Oncol; 2017; 6():4. PubMed ID: 28101432
    [Abstract] [Full Text] [Related]

  • 42. Can eculizumab be discontinued in aHUS?: Case report and review of the literature.
    Sahutoglu T, Basturk T, Sakaci T, Koc Y, Ahbap E, Sevinc M, Kara E, Akgol C, Caglayan FB, Unsal A, Daha MR.
    Medicine (Baltimore); 2016 Aug; 95(31):e4330. PubMed ID: 27495036
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Eculizumab for the treatment of atypical hemolytic uremic syndrome: case report and revision of the literature].
    Vaisbich MH, Henriques Ldos S, Watanabe A, Pereira LM, Metran CC, Malheiros DA, Modanez F, Silva JD, Vieira S, Macedo AC, Massarope B, Furusawa EA, Schvartsman BG.
    J Bras Nefrol; 2013 Aug; 35(3):237-41. PubMed ID: 24100744
    [Abstract] [Full Text] [Related]

  • 45. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S.
    Nefrologia; 2015 Aug; 35(5):421-47. PubMed ID: 26456110
    [Abstract] [Full Text] [Related]

  • 46. Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.
    Salameh H, Abu Omar M, Alhariri A, Kisra S, Qasem A, Abdulhak AB.
    Am J Ther; 2016 Aug; 23(4):e1110-5. PubMed ID: 25486517
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. A Case Report and Literature Review of Eculizumab Withdrawal in Atypical Hemolytic-Uremic Syndrome.
    Quiroga B, de Lorenzo A, Vega C, de Alvaro F.
    Am J Case Rep; 2016 Dec 15; 17():950-956. PubMed ID: 27974740
    [Abstract] [Full Text] [Related]

  • 49. Eculizumab therapy on a patient with co-existent lupus nephritis and C3 mutation-related atypical haemolytic uremic syndrome: a case report.
    Kim MJ, Lee H, Kim YH, Jin SY, Kim HJ, Oh D, Jeon JS.
    BMC Nephrol; 2021 Mar 10; 22(1):86. PubMed ID: 33691638
    [Abstract] [Full Text] [Related]

  • 50. Nephromegaly in an infant with atypical hemolytic-uremic syndrome resolving successfully with eculizumab.
    Kumar G.
    Saudi J Kidney Dis Transpl; 2018 Mar 10; 29(4):967-970. PubMed ID: 30152436
    [Abstract] [Full Text] [Related]

  • 51. Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome.
    Mussoni MP, Veneziano FA, Boetti L, Tassi C, Calisesi C, Nucci S, Rigotti A, Panzini I, Ardissino G.
    Transfus Apher Sci; 2014 Oct 10; 51(2):134-6. PubMed ID: 25294113
    [Abstract] [Full Text] [Related]

  • 52. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
    Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N.
    Intern Med J; 2015 Oct 10; 45(10):1054-65. PubMed ID: 26247170
    [Abstract] [Full Text] [Related]

  • 53. C3:CH50 ratio as a proposed composite marker for eculizumab monitoring in atypical hemolytic uremic syndrome: Preliminary results.
    Kerboua KE, Haiba F, Batouche D.
    J Immunoassay Immunochem; 2017 Oct 10; 38(2):178-189. PubMed ID: 27617501
    [Abstract] [Full Text] [Related]

  • 54. Activated Prothrombin Complex Concentrate-Induced Atypical Hemolytic Uremic Syndrome Treated with Eculizumab.
    Tsai HHC, Moyers JT, Moore CJ, Thinn M.
    Am J Case Rep; 2021 Mar 08; 22():e929616. PubMed ID: 33678802
    [Abstract] [Full Text] [Related]

  • 55. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
    Asif A, Nayer A, Haas CS.
    J Nephrol; 2017 Jun 08; 30(3):347-362. PubMed ID: 27848226
    [Abstract] [Full Text] [Related]

  • 56. Eculizumab for paediatric patients with atypical haemolytic uraemic syndrome: full dataset analysis of post-marketing surveillance in Japan.
    Ito S, Hataya H, Ashida A, Hamada R, Ishikawa T, Ishikawa Y, Shimono A, Konomoto T, Miyazawa T, Ogura M, Tanaka K, Kagami S.
    Nephrol Dial Transplant; 2023 Feb 13; 38(2):414-424. PubMed ID: 35438790
    [Abstract] [Full Text] [Related]

  • 57. [A case of atypical hemolytic uremic syndrome successfully weaned from plasma exchange by treatment with eculizumab].
    Nagata A, Ohara A, Wakasugi D, Natori C, Ito S, Taguchi K, Fukami K, Okuda S.
    Nihon Jinzo Gakkai Shi; 2014 Feb 13; 56(5):606-11. PubMed ID: 25130033
    [Abstract] [Full Text] [Related]

  • 58. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.
    Gately R, San A, Kurtkoti J, Parnham A.
    Nephrology (Carlton); 2017 Feb 13; 22 Suppl 1():32-35. PubMed ID: 28176475
    [Abstract] [Full Text] [Related]

  • 59. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
    Abe T, Sasaki A, Ueda T, Miyakawa Y, Ochiai H.
    Medicine (Baltimore); 2017 Feb 13; 96(6):e6056. PubMed ID: 28178155
    [Abstract] [Full Text] [Related]

  • 60. First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients.
    Yüksel S, Evrengül H, Özçakar ZB, Becerir T, Yalçın N, Korkmaz E, Ozaltin F.
    Paediatr Drugs; 2016 Dec 13; 18(6):413-420. PubMed ID: 27646857
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.